<code id='4E30F278CF'></code><style id='4E30F278CF'></style>
    • <acronym id='4E30F278CF'></acronym>
      <center id='4E30F278CF'><center id='4E30F278CF'><tfoot id='4E30F278CF'></tfoot></center><abbr id='4E30F278CF'><dir id='4E30F278CF'><tfoot id='4E30F278CF'></tfoot><noframes id='4E30F278CF'>

    • <optgroup id='4E30F278CF'><strike id='4E30F278CF'><sup id='4E30F278CF'></sup></strike><code id='4E30F278CF'></code></optgroup>
        1. <b id='4E30F278CF'><label id='4E30F278CF'><select id='4E30F278CF'><dt id='4E30F278CF'><span id='4E30F278CF'></span></dt></select></label></b><u id='4E30F278CF'></u>
          <i id='4E30F278CF'><strike id='4E30F278CF'><tt id='4E30F278CF'><pre id='4E30F278CF'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:68
          Adobe

          Hospitals and medical groups say they’re still reeling from the effects of the cyberattack on a UnitedHealth Group subsidiary, but the massive company at the center of the debacle has so far emerged largely unscathed, with executives on Tuesday praising its strength and resilience.

          The almost $8 billion UnitedHealth made on operations in the first three months of 2024 was roughly the same as the prior-year period. Despite the Change Healthcare cyberattack, the health insurance, provider, and technology conglomerate reaffirmed its adjusted earnings outlook for the year, and its share price grew more than 5% by market close.

          advertisement

          Ultimately, UnitedHealth said it’ll take an up to $1.6 billion hit from the cyberattack this year, a drop in the bucket for a company that’s expected to generate $400 billion in revenue.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Eli Lilly’s chief scientist on obesity drugs, gene editing, and more
          Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

          DanSkovronsky,EliLilly'schiefscientificofficer,atthe2023STATSummit.STATPHILADELPHIA—Inasense,theannu

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

          PhotobyKEREMYUCEL/AFPviaGettyImagesSANFRANCISCO—MayoClinichassignedSiliconValleytechstartupCerebrasa